The first to become available on the market was Byetta (exenatide), which was approved for the management of type 2 diabetes in 2005
Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes
Scassellati C, Galoforo AC, Bonvicini C, Esposito C, Ricevuti G (2020) Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders
FIGURE 9 Statements Data availability statement The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author
The arGLP-1 s present other differences in clinically relevant biological properties (half-life, dosing interval and molecular weight)
10.3389/fendo.2024.1333778 Front Endocrinol